COMMUNIQUÉS West-GlobeNewswire

CalciMedica Announces One-for-Five Reverse Stock Split
27/08/2026
CalciMedica’s Common Stock to Begin Trading on a Post-Split Adjusted Basis on August 31, 2026 LA JOLLA, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- CalciMedica Inc. (“CalciMedica” or the “Company”) (Nasdaq: CALC), a [...]
National Can-RISE Study to Help Close Critical Gaps in Menopause Research
27/08/2026
The first national investigator-led study focused on Canadian women’s experiences of menopause and the menopausal transition is now inviting participants, in partnership with GreenShield and supported by a charitable [...]
L’étude Can-RISE nationale aide à combler les lacunes en recherche sur la ménopause
27/08/2026
En collaboration avec GreenShield et à travers une subvention philanthropique d’Organon, les personnes admissibles sont désormais invitées à prendre part à la première étude nationale menée par des chercheurs reposant [...]
Moleculin CEO, Walter Klemp, Participates in the Virtual Investor “Why Now” On-Demand Conference
27/08/2026
- Video webcast now available here HOUSTON, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that it participated in the Virtual Investor “Why [...]
Ernexa Therapeutics Participates in the Virtual Investor "Why Now" On-Demand Conference
27/08/2026
Video webcast now available here CAMBRIDGE, Mass., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and [...]
GRI Bio Featured in "Why Now" On-Demand Video Webcast
27/08/2026
Video webcast now available here LA JOLLA, CA, Aug. 27, 2026 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company developing innovative therapies for inflammatory, [...]
Akari Therapeutics Participates in the Virtual Investor "Why Now" On-Demand Conference
27/08/2026
Video webcast now available here TAMPA, Fla. and LONDON, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel [...]
Outlook Therapeutics CEO, Bob Jahr, Participates in the Virtual Investor “Why Now” On-Demand Conference
27/08/2026
Video webcast now available here ISELIN, N.J., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on the development and commercialization of LYTENAVA™ ( [...]
Daré Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor “Why Now” On-Demand Series
27/08/2026
Video webcast now available here SAN DIEGO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between [...]
AIM ImmunoTech Participates in the Virtual Investor ‘Why Now’ On-Demand Conference
27/08/2026
Video webcast now available here OCALA, Fla., Aug. 27, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it participated in the Virtual Investor "Why Now" on [...]
POSSIBLE® by Standard Process® Launches Peanut Butter Banana Cacao Snack Bar
27/08/2026
A Whole Food Snack Bar Designed to Support Real Life PALMYRA, Wis., Aug. 27, 2026 (GLOBE NEWSWIRE) -- POSSIBLE ® by Standard Process ® today announced the launch of its new POSSIBLE ® Peanut Butter Banana Cacao Snack [...]
Philips and Imricor launch cardiac interventional MR lab solution, expanding longstanding collaboration
27/08/2026
August 27, 2026 The solution combines Philips' high-performance 1.5T MRI platform and advanced interventional workflow capabilities with Imrico r' s exclusive portfolio of systems and consumables for MR-guided cardiac [...]
Myriad Genetics to Present at 2026 Wells Fargo Healthcare Conference
27/08/2026
SALT LAKE CITY, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces Myriad management will present at the 21 st [...]
Ally Medical ER Unleashes the Final Stretch of Its Pet Supply Drive with Over 7,000 Donations and a Dog Named Ally Bear
27/08/2026
Two milestones help fuel the freestanding ER's donation drive supporting Texas animals in need throughout the month of August AUSTIN, Texas, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Ally Medical Emergency Room has surpassed [...]
Correction: Entera to Participate in Upcoming Fall Investor Conferences
27/08/2026
TEL AVIV, Israel, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that the Company’s Chief Executive Officer, [...]
HighLife Receives CE Mark Approval for Clarity Valve, the Next-Generation Valve for the HighLife TMVR System
27/08/2026
Paris, France - August 27, 2026 – HighLife SAS, a medical technology company focused on the development of a unique transcatheter mitral valve replacement (“TMVR”) system to treat patients suffering from mitral [...]
Orion Corporation to commence acquisition of own shares for its share-based incentive plans
27/08/2026
ORION CORPORATION STOCK EXCHANGE RELEASE – OTHER INFORMATION DISCLOSED ACCORDING TO THE RULES OF THE EXCHANGE 27 AUGUST 2026 at 13.00 EEST Orion Corporation to commence acquisition of own shares for its share-based [...]
Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference
27/08/2026
DEER PARK, Ill., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare [...]
HighLife Receives CE Mark Approval for Clarity Valve, the Next-Generation Valve for the HighLife TMVR System
27/08/2026
Paris, France - August 27, 2026 – HighLife SAS, a medical technology company focused on the development of a unique transcatheter mitral valve replacement (“TMVR”) system to treat patients suffering from mitral [...]

Pages